×

Sign In

Search
Home

Sage rejects Biogen’s takeover offer, to explore strategic alternatives

By Thomson Reuters Jan 27, 2025 | 8:28 AM

(Reuters) – Sage Therapeutics said on Monday that its board has unanimously rejected the takeover offer it received from Biogen and added that its board of directors has initiated a process to explore strategic alternatives.

(Reporting by Sneha S K; Editing by Tasim Zahid)

UK's Reeves gears up for fight to get economy growing again

BOJ discussed neutral rate estimate at December meeting, minutes show

Casualties feared as stampede breaks out at India's Maha Kumbh festival, The Hindu reports citing PTI

US issues new waiver for humanitarian aid amid freeze

Analysis-HSBC's global brand in the balance as it doubles down on Asia bet

Senators raise concern about Chinese influence on Panama Canal operations

Privacy Policy
Terms Of Service

Midwest Communications, Inc.

Copyright © 2025. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.